More tools:Markets·Screener·Research·Chat

BioLineRX Ltd (BLRX) Financial Statements

BioLineRX Ltd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001Y26MC7
XNAS · usd
2.59▲ 0.00 (0.00%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close2.59
Day's Range2.55 – 2.78
52-Week Range2.13 – 4.56
Volume19.8K
Avg Volume20.4K
Share Statistics
Shares Outstanding
Employees24
ExchangeXNAS
Listed2011-07-25
Share count as of March 8, 2026
Loading Income Statement…
Key questions about BioLineRX Ltd (BLRX)
What is BioLineRX Ltd's Market Cap?
BioLineRX Ltd's Market Cap is $6.8B, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's Enterprise Value?
BioLineRX Ltd's Enterprise Value is $6.7B, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's Price / Sales?
BioLineRX Ltd's Price / Sales is 4857.8×, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's EV / Revenue?
BioLineRX Ltd's EV / Revenue is 4848.4×, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's EV / EBITDA?
BioLineRX Ltd's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's Revenue (TTM)?
BioLineRX Ltd's Revenue (TTM) is $1.4M, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's Net Income (TTM)?
BioLineRX Ltd's Net Income (TTM) is -$10.1M, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's EBITDA?
BioLineRX Ltd's EBITDA is -$11.7M, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's Diluted EPS (TTM)?
BioLineRX Ltd's Diluted EPS (TTM) is -0.00, based on as-reported figures from SEC (XBRL) filings.
What is BioLineRX Ltd's EBITDA Margin?
BioLineRX Ltd's EBITDA Margin is -838.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Profit or loss [abstract]
ROYALTY REVENUES
COST OF REVENUES
GROSS PROFIT
RESEARCH AND DEVELOPMENT EXPENSES
GENERAL AND ADMINISTRATIVE EXPENSES
OPERATING LOSS
NON-OPERATING INCOME (EXPENSES), NET
Interest Income
FINANCIAL EXPENSES
NET INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
EARNINGS (LOSS) PER ORDINARY SHARE – BASIC ATTRIBUTABLE TO OWNERS OF THE COMPANY
EARNINGS (LOSS) PER ORDINARY SHARE – DILUTED ATTRIBUTABLE TO OWNERS OF THE COMPANY